# Research Paper Outline

## Physics-Constrained Generative Models of Neural Tissue: Towards Ab Initio Simulation of Neurogenesis

---

## Abstract (200 words)

**Gap**: Current computational models of neurogenesis rely on phenomenological descriptions that obscure the physical mechanisms governing neural stem cell fate decisions and functional integration of new neurons.

**Method**: We present NeuroSim, a physics-constrained simulation framework that models neural tissue from first principles. The framework couples electrodiffusion (Nernst-Planck-Poisson), fluid dynamics (Navier-Stokes), metabolic transport (reaction-diffusion with Michaelis-Menten kinetics), and thermodynamics (bioheat equation) across scales from molecular (nm) to organ (cm). Neural stem cell dynamics are governed by physically-derived signals including mechanical strain, electrical field gradients, and morphogen concentrations. We employ Bayesian optimization to discover parameter combinations that maximize neurogenesis while maintaining functional network integration.

**Finding**: Our optimization identifies a minimal intervention set (BDNF concentration, theta-frequency entrainment, substrate stiffness) that promotes neural stem cell proliferation and differentiation in simulated Alzheimer's pathology. Comparative analysis reveals that tau pathology (transport disruption) is more reversible through neurogenesis than amyloid pathology (diffusion barriers), suggesting differential therapeutic targets.

**Implication**: Physics-constrained neural simulation enables mechanistic hypothesis generation for neurogenesis-based therapeutics. The framework provides a computational platform for screening intervention strategies before experimental validation.

---

## 1. Introduction

### 1.1 The computational challenge of neurogenesis
- Complexity spanning 9 orders of magnitude (nm to cm)
- Current modeling approaches: agent-based, network, continuum
- Limitations: phenomenological parameters, lack of conservation laws

### 1.2 Physics-first philosophy
- First-principles modeling in other domains (climate, materials)
- Every parameter must map to measurable physical quantity
- Emergence vs. prescription: letting complexity arise from constraints

### 1.3 Neurogenesis in disease context
- Adult neurogenesis in SVZ and hippocampal dentate gyrus
- Decline in Alzheimer's disease
- Therapeutic potential of stimulating endogenous neurogenesis

### 1.4 Present contribution
- Multiscale physics-constrained simulation framework
- ML-driven parameter optimization for neurogenesis
- Application to Alzheimer's pathology reversal

---

## 2. Methods

### 2.1 Mathematical Framework

#### 2.1.1 Spatial domain and boundary conditions
- Cranial geometry (ellipsoidal constraint)
- Intracranial pressure with pulsatility
- CSF-parenchyma interface conditions

#### 2.1.2 Electrodiffusion system
- Nernst-Planck flux equations for Na⁺, K⁺, Ca²⁺, Cl⁻
- Poisson equation for electric potential
- Hodgkin-Huxley extended with fractal dendritic geometry
- Markov channel state models

#### 2.1.3 Fluid dynamics
- Navier-Stokes for CSF flow
- Blood flow as boundary oxygen/glucose source
- Darcy flow in porous parenchyma

#### 2.1.4 Metabolic coupling
- Oxygen transport and consumption (Michaelis-Menten)
- ATP synthesis and utilization budget
- Glycolytic vs. oxidative metabolism switching

#### 2.1.5 Thermodynamics
- Bioheat equation with metabolic sources
- Temperature-dependent rate coefficients
- Entropy production as system health metric

### 2.2 Neural Stem Cell Model

#### 2.2.1 Cell cycle representation
- G0 → G1 → S → G2 → M state machine
- Cyclin/CDK network with physical signal integration
- Symmetric vs. asymmetric division outcomes

#### 2.2.2 Physical signal transduction
- Mechanotransduction: YAP/TAZ pathway with substrate stiffness
- Electrical sensitivity: NMDA-dependent calcium signaling
- Morphogen gradients: BDNF, Wnt, Notch

#### 2.2.3 Differentiation trajectory
- Stem → Progenitor → Neuroblast → Mature neuron
- Marker gene regulatory network (Nestin, Sox2, DCX, NeuN)
- Functional integration criteria

### 2.3 Pathology Representation

#### 2.3.1 Amyloid-β as diffusion barrier
- Plaque geometry and distribution
- Effective diffusion coefficient reduction
- Tortuosity modeling

#### 2.3.2 Tau as transport disruption
- Microtubule stability coefficient
- Axonal transport velocity degradation
- Phosphorylation dynamics

#### 2.3.3 Neuroinflammation
- Microglial activation state
- Cytokine field equations
- Feedback on stem cell quiescence

### 2.4 Optimization Framework

#### 2.4.1 Parameter space
- 26-dimensional intervention space
- Physical constraints on parameter ranges
- Biologically plausible combinations

#### 2.4.2 Objective function
- Neurogenesis rate
- Functional integration metrics (LTP, connectivity)
- Network performance (pattern separation/completion)
- Energy efficiency (bits/ATP)

#### 2.4.3 Bayesian optimization
- Gaussian process surrogate model
- Expected improvement acquisition function
- Exploration-exploitation trade-off

### 2.5 Numerical Implementation

#### 2.5.1 Spatial discretization
- Voxel grid (1 μm resolution)
- Finite volume method for conservation
- Sparse matrix representations

#### 2.5.2 Time integration
- Adaptive timestep (1 ns - 1 ms)
- CVODE for stiff ODEs
- Operator splitting for multiphysics

#### 2.5.3 Validation strategy
- Conservation law verification
- Comparison to experimental benchmarks
- Sensitivity analysis

---

## 3. Results

### 3.1 Framework Validation
- Action potential reproduction vs. experimental recordings
- Ion concentration dynamics vs. imaging data
- Metabolic coupling vs. BOLD-fMRI correlates

### 3.2 Neurogenesis Parameter Discovery
- Convergence of optimization
- Top parameters: BDNF > Wnt > theta-frequency > ATP/ADP
- Parameter interactions and synergies

### 3.3 Pathology-Specific Reversibility
- Amyloid pathology: limited recovery (diffusion constraints persistent)
- Tau pathology: higher recovery (new neurons bypass damaged transport)
- Metabolic dysfunction: moderate recovery (improved with enhanced oxygen)

### 3.4 Mechanistic Insights
- Theta rhythm entrains stem cell calcium oscillations
- BDNF gradient guides growth cone navigation around plaques
- Optimal stiffness balances mechanotransduction with motility

### 3.5 Predicted Intervention Protocols
- Acute intervention (24h pulse)
- Chronic intervention (continuous low-dose)
- Combination therapy optimization

---

## 4. Discussion

### 4.1 Relation to existing models
- Comparison with phenomenological approaches
- Advantages of physics constraints
- Limitations and approximations

### 4.2 Biological plausibility
- Agreement with known neurogenesis factors
- Novel predictions for experimental testing
- Potential off-target effects

### 4.3 Therapeutic translation pathway
- In vitro validation (organoids, slice cultures)
- In vivo testing (rodent models)
- Clinical trial design considerations

### 4.4 Limitations
- Scale truncation and coarse-graining
- Unknown parameters and uncertainties
- Computational cost constraints

### 4.5 Future directions
- Genetic/epigenetic layer integration
- Patient-specific parameter estimation
- Real-time model-predictive control

---

## 5. Figures (7 total)

1. **Multi-scale schematic**: Quantum → molecular → cellular → network → organ
2. **Equation validation**: HH spikes, ion kinetics, diffusion, metabolism
3. **Digital environment**: Voxel grid, adaptive stepping, conservation
4. **Parameter optimization**: Importance, landscape, Pareto front
5. **Alzheimer's reversal**: Pathology comparison, recovery trajectories
6. **Visualization examples**: Multi-scale rendering
7. **Translation pathway**: Discovery → validation → clinic

---

## 6. Supplementary Materials

### S1. Complete equation derivations
### S2. Parameter tables with sources
### S3. Numerical stability analysis
### S4. Additional optimization results
### S5. Code repository documentation

---

## Author Contributions

- Conceptualization:
- Methodology:
- Software:
- Validation:
- Writing - Original Draft:
- Writing - Review & Editing:
- Visualization:
- Supervision:

## Acknowledgments

## Competing Interests
The authors declare no competing interests.

## Data Availability
All simulation code and data are available at [repository URL].

## Code Availability
The NeuroSim framework is available under [license] at [repository URL].
